ClassID:

110274

C12N2740/10041 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae Use of virus, viral particle or viral elements as a vector

Sub-classes:
Recent Application in this class:
#1
20250283037
2025-09-11

METHODS FOR STIMULATING AND TRANSDUCING T CELLS

#2
20250011814
2025-01-09

RETROVIRAL TRANSDUCTION USING POLOXAMERS

#3
20240189352
2024-06-13

T-CELL RECEPTORS SPECIFIC FOR BOTH RAC1- AND RAC2-DERIVED MUTATED EPITOPES

#4
20240052311
2024-02-15

END-TO-END CELL THERAPY AUTOMATION

#5
20230381276
2023-11-30

INTERLEUKIN-21 MUTEIN/ ANTI-PD-1 ANTIBODY CONJUGATES

#6
20230183745
2023-06-15

Retroviral vector

#7
20230183744
2023-06-15

Digital-to-analog conversion apparatus and method having signal calibration mechanism

#8
20230130635
2023-04-27

RETROVIRAL TRANSDUCTION USING POLOXAMERS

#9
20220406435
2022-12-22

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

#10
20220282214
2022-09-08

End-to-end cell therapy automation

#11
20220282213
2022-09-08

End-to-end cell therapy automation

#12
20220282212
2022-09-08

END-TO-END CELL THERAPY AUTOMATION

#13
20210171922
2021-06-10

Lysosomal storage disease enzymes

#14
20210010026
2021-01-14

Retroviral transduction using poloxamers

#15
20200071670
2020-03-05

End-to-end cell therapy automation

#16
20200063113
2020-02-27

Lysosomal storage disease enzymes

#17
20190262309
2019-08-29

Enhanced Gene Delivery to Natural Killer Cells, Hematopoietic Stem Cells and Macrophages

#18
20190211358
2019-07-11

Retroviral Vector

#19
20190194615
2019-06-27

T cell compositions

#20
20190169572
2019-06-06

End-to-end cell therapy automation

#21
20190127708
2019-05-02

MESSENGER RNA BASED VIRAL PRODUCTION

#22
20190119700
2019-04-25

Lentiviral vector capable of directly reflecting type I interferon response, preparation method thereof, and applications thereof

#23
20190111071
2019-04-18

Method for promoting muscle regeneration

#24
20190099451
2019-04-04

RETROVIRAL CONSTRUCT HARBORING A LET-7 INSENSITIVE NUCLEIC ACID ENCODING HMGA2 AND METHODS OF USE THEREOF

#25
20190076458
2019-03-14

METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

#26
20190046611
2019-02-14

Interleukin-21 mutein/ anti-PD-1 antibody conjugates

#27
20180171357
2018-06-21

Self-limiting viral vectors encoding nucleases

#28
20180016600
2018-01-18

Retroviral transduction using poloxamers

#29
20170314000
2017-11-02

Lysosomal storage disease enzymes

#30
20170240920
2017-08-24

Method and means for purifying retroviral vectors

#31
20160122727
2016-05-05

MESSENGER RNA BASED VIRAL PRODUCTION

#32
20160074372
2016-03-17

Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses

#33
20160067228
2016-03-10

Methods and compositions for attenuating anti-viral transfer vector immune responses

#34
20150079052
2015-03-19

Methods for amelioration of autoimmune disease using stem cells transduced with T cell receptors from IL-10 secreting T cells

#35
20150079050
2015-03-19

Method for producing viral vector

#36
20150064788
2015-03-05

Retroviral transduction using poloxamers

#37
20150051267
2015-02-19

BICISTRONIC GENE TRANSFER TOOLS FOR DELIVERY OF miRNAS AND PROTEIN CODING SEQUENCES

#38
20140377245
2014-12-25

METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE

#39
20140369977
2014-12-18

Targeting Tumor Neovasculature with Modified Chimeric Antigen Receptors

#40
20140349404
2014-11-27

Method for gene transfer

#41
20140079725
2014-03-20

Immune suppressor and its use

#42
20120122716
2012-05-17

CELL LINE DERIVED FROM THE EPITHELIAL LINING OF THE HUMAN ENDOLYMPHATIC SAC IN THE INNER EAR